CareSTEPS: A Supportive Care Program for the Caregivers of Advanced Lung Cancer Patients

April 19, 2024 updated by: Hoda Badr, Baylor College of Medicine
The CareSTEPS intervention fills an important service gap by providing education, skills training, and support to the caregivers of advanced lung cancer patients on active treatment. The home-based delivery format will facilitate future dissemination and outreach. By empowering families with the skills they need to provide care and meet the challenges of lung cancer, this intervention holds great promise for improving caregiver quality of life (QOL), patient QOL, and the quality of palliative and supportive care services offered to patients with advanced cancer and their families.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The profound symptom burden associated with advanced lung cancer (LC) makes caregiving a complex and burdensome task. Despite the input of outpatient palliative care services, LC families are often unprepared for caregiving, have low self-efficacy for managing symptoms at home, report high rates of physical and emotional distress, and receive very little skills training or psychosocial care. To date, the few psychosocial intervention trials targeting the caregivers of advanced cancer patients that have been conducted have mostly targeted the families of hospice patients, have not been well-integrated into routine palliative care, and have not addressed the specific needs of LC caregivers. Based on our published and recently completed pilot work in LC, the investigators have developed a psychosocial intervention called CareSTEPS (self-Care, Stress management, sympTom management, Effective communication, Problem-solving, and Social support). CareSTEPS is grounded by Self Determination Theory (SDT) which focuses on individuals' needs for developing autonomy (a sense of choice and volition), competence (self-efficacy), and relatedness (a sense of belonging and connection). It: 1) teaches skills to enhance caregiver competence for managing symptoms, practicing self-care, and coping with cancer; 2) supports caregiver autonomy by providing a clear rationale for recommendations and a variety of options to encourage choice and elaboration; and, 3) seeks to improve caregivers' sense of relatedness by teaching strategies for effective communication and soliciting/accepting social support. 200 LC patients will be enrolled within one month of treatment initiation (baseline) and their caregivers and randomize them to either a usual medical care (UMC) condition or the CareSTEPS intervention (caregivers receive a manual and six 45-minute weekly counseling sessions by telephone). The primary aim is to determine the impact of the CareSTEPS intervention on caregiver self-care behaviors, physical and emotional QOL, and satisfaction with care. Secondary aims are to: 1a) examine the effects of CareSTEPS on the SDT constructs of competence, autonomy, and relatedness; 1b) test whether caregiver competence, autonomy and relatedness mediate the effects of CareSTEPS on caregiver outcomes as hypothesized; 2) explore whether sociodemographic, medical, and relationship factors moderate the effects of the CareSTEPS intervention on SDT constructs; and, 3) explore the effects of CareSTEPS on patient QOL, palliative care utilization, and satisfaction with care. CareSTEPS fills an important service gap by providing education, skills training, and support to the caregivers of advanced LC patients who are on active treatment. The home-based delivery format will facilitate future dissemination and outreach. By empowering families with the skills they need to provide care and meet the challenges of LC, CareSTEPS holds great promise for improving caregiver QOL, patient QOL, and the quality of palliative/supportive care services for advanced cancer patients and their families.

Study Type

Interventional

Enrollment (Actual)

317

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Texas
      • Houston, Texas, United States, 77030
        • Baylor College of Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patient has stage 3B or 4 NSLC or extensive stage SCLC and is within one month of treatment initiation
  • Patient is spending more than 50% of time out of bed on a daily basis, as measured by an ECOG Performance Status rating of level 0, 1, or 2
  • Patient has a spouse/partner other or close family member who he/she defines as the primary caregiver
  • Patient and caregiver > 18 years
  • Patient/caregiver has the ability to read and understand English at a sixth grade level, as determined by his/her ability to understand the consent form
  • Patient/caregiver can provide informed consent

Exclusion Criteria:

  • Individuals with diminished mental capacity
  • Prisoners
  • Children
  • Pregnant Women
  • Fetuses

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: CareSTEPS
CareSTEPS provides skills training in six domains that are central to the caregiving role: self-care, stress management, symptom management, effective communication, problem-solving, and social support.
Caregivers receive a workbook and 6 one-hour telephone sessions with a trained interventionist.
No Intervention: Usual Medical Care (UMC)
Patients receive standard oncologic and generalist palliative care from their healthcare team.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Caregiver Depression
Time Frame: 8 weeks
PROMIS Depression Short Form
8 weeks
Caregiver Anxiety
Time Frame: 8 weeks
PROMS Anxiety Short form
8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Caregiver Depression
Time Frame: 6 months
PROMIS Depression Short Form
6 months
Caregiver burden
Time Frame: 8 weeks and 6 months
Zarit Burden Interview
8 weeks and 6 months
Patient emotional quality of life
Time Frame: 8 weeks and 6 months
PROMIS Depression and Anxiety Short Forms
8 weeks and 6 months
Caregiver Anxiety
Time Frame: 6 months
PROMIS Anxiety Short Form
6 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient physical quality of life
Time Frame: 8 weeks and 6 months
MD Anderson Symptom Inventory (MDASI-LC)
8 weeks and 6 months
Caregiver Self-care behaviors
Time Frame: 8 weeks and 6 months
Self-Management Behaviors (based on Lorig, 1996) Self-care (based on Schulz, 1999)
8 weeks and 6 months
Caregiver Satisfaction with Care
Time Frame: 8 weeks and 6 months
FAMCARE Scale
8 weeks and 6 months
Caregiver physical quality of life
Time Frame: 8 weeks and 6 months
Physical summary scale of the Short Form 12 (SF12)
8 weeks and 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Hoda Badr, PhD, Baylor College of Medicine

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2014

Primary Completion (Actual)

June 1, 2020

Study Completion (Actual)

December 1, 2020

Study Registration Dates

First Submitted

April 7, 2015

First Submitted That Met QC Criteria

April 10, 2015

First Posted (Estimated)

April 13, 2015

Study Record Updates

Last Update Posted (Actual)

April 22, 2024

Last Update Submitted That Met QC Criteria

April 19, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Lung Cancer

3
Subscribe